Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Contezolid by MicuRx Pharmaceuticals for Diabetic Foot Infection (DFI): Likelihood of Approval
Contezolid is under clinical development by MicuRx Pharmaceuticals and currently in Phase III for Diabetic Foot Infection (DFI). According to...